Cosmos Pharmaceutical Corp. Reports FY26 Revenue of 1.1 trillion, Up 9%
TOKYO, Jul 13 (Pulse News Wire) – Cosmos Pharmaceutical Corp. (3349.T) reported consolidated results for fiscal year 2026 ending May. Revenue was ¥1.1 trillion (+8.7% YoY). operating profit was ¥64,99
TOKYO, Jul 13 (Pulse News Wire) – Cosmos Pharmaceutical Corp. (3349.T) reported consolidated results for fiscal year 2026 ending May.
Revenue was ¥1.1 trillion (+8.7% YoY). operating profit was ¥64,996 million (+6.8%). net profit attributable to shareholders was ¥44,614 million (+3.4%).
Total assets stood at ¥600 billion with an equity ratio of 47.6%. The company declared an annual dividend of ¥44 per share. The full-year forecast for the current fiscal year is revenue of ¥580 billion (+8.5%).
Financial results — FY2026/5 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥1,099,583M | +8.7% |
| Operating profit | ¥64,996M | +6.8% |
| Net profit | ¥44,614M | +3.4% |
Source: TDNet filing · Figures in millions of yen